Rani Therapeutics

📍 San Jose, United States🗓 Founded 2012👥 105 employees💰 Last funded Apr 2018
Biotechnology🌐 ranitherapeutics.com
Website LinkedIn
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs. Millions of patients with chronic conditions require biologic drugs, the vast majority of which must be injected. We have developed the RaniPill™ technology to replace subcutaneous or IV injections of biologics with an oral pill. The RaniPill™ capsule is designed to deliver an injection to the intestinal wall, where there are no sharp pain receptors, and has achieved bioavailability similar to subcutaneous injections. We believe oral versions of biologics will have the potential to transform medicine and improve outcomes for the millions of patients who currently rely on chronic self-injections.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Rani Therapeutics?
Rani Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Rani Therapeutics last raise funding?
The most recent investment in Rani Therapeutics recorded on gritt.io was in April 2018.
When was Rani Therapeutics founded?
Rani Therapeutics was founded in 2012.
What industry is Rani Therapeutics in?
Rani Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Rani Therapeutics based?
Rani Therapeutics is headquartered in San Jose, United States.